Ignite Creation Date:
2024-05-06 @ 6:18 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05615051
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2022-11-07
Brief Title:
Influence of Implant Surface Decontamination on the Reconstructive Outcomes of Peri-implantitis
Sponsor:
Center of Implantology Oral and Maxillofacial Surgery Badajoz Spain
Organization:
Center of Implantology Oral and Maxillofacial Surgery Badajoz Spain
Study Overview
Official Title:
Influence of Implant Surface Decontamination on the Reconstructive Outcomes of Peri-implantitis A Randomized Clinical Trial
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Two groups are aimed at being investigated in three centers CICOM Clinica Branemark and Clinica Joan Pi
Test group Group electrolytic approach EA Mechanical detoxification using curettes NiTi brushes EA GalvoSurge during 2 minutes
Control group Group hydrogen peroxide HP Mechanical detoxification using curettes NiTi brushes hydrogen peroxide 5 for 2 minutes soaked in a gauze Patients group selection will be randomly allocated For patients whom their personal clinical record ends in a number from 0 to 4 will be included in the test group while for patients whom their personal clinical record ends from 5-9 will be included in the control group
The infra-osseous component will be regenerated using xenograft Creos NB autogenous bone in a ratio 11 harvested from the adjacent area A resorbable membrane Creos NB will be placed to compartmentalize the infra-osseous component following a poncho-like approach
Test group Group electrolytic approach EA Mechanical detoxification using curettes NiTi brushes EA GalvoSurge during 2 minutes
Control group Group hydrogen peroxide HP Mechanical detoxification using curettes NiTi brushes hydrogen peroxide 5 for 2 minutes soaked in a gauze Patients group selection will be randomly allocated For patients whom their personal clinical record ends in a number from 0 to 4 will be included in the test group while for patients whom their personal clinical record ends from 5-9 will be included in the control group
The infra-osseous component will be regenerated using xenograft Creos NB autogenous bone in a ratio 11 harvested from the adjacent area A resorbable membrane Creos NB will be placed to compartmentalize the infra-osseous component following a poncho-like approach
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None